FDA Inspection 1003868 — Central Jersey Blood Center, Inc.
The FDA completed an inspection of Central Jersey Blood Center, Inc. on Feb 28, 2017 in Toms River, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 28, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Toms River, NJ (United States)